Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna

作者: Georgy Viktorovich Tets , Dmitry Dmitrievich Genkin , Viktor Veniaminovich Tets

DOI:

关键词:

摘要: The invention relates to medicine and veterinary science. inventive method for treating human diseases associated with modifications of the qualitative and/or quantitative composition blood extracellular DNA, namely generalised infection induced by bacteria, fungi protozoa, atherosclerosis, pancreatic diabetes, allergic delayed response hypersensitivity due somatic cell gene mutations consists in injecting an agent destroying DNA which is embodied form DNAse enzyme injected into a systemic circulation doses modify electrophoretic profile detectable pulse-electrophoresis. Said can be at regimes ensuring level plasma DNA-hydrolytic activity measured higher than 150 Kunz units per litre during total time 12 hours day.

参考文章(23)
Gérard Emilien, Jean-Marie Maloteaux, Michel Ponchon, Pharmacological management of diabetes: recent progress and future perspective in daily drug treatment. Pharmacology & Therapeutics. ,vol. 81, pp. 37- 51 ,(1999) , 10.1016/S0163-7258(98)00034-5
Robert A. Millbrae Lazarus, Clark Qun San Francisco Pan, Human DNase I hyperactive variants ,(1997)
Armine M. Sefton, Mechanisms of Antimicrobial Resistance Drugs. ,vol. 62, pp. 557- 566 ,(2002) , 10.2165/00003495-200262040-00001
Hagop Youssoufian, Reed E. Pyeritz, Mechanisms and consequences of somatic mosaicism in humans Nature Reviews Genetics. ,vol. 3, pp. 748- 758 ,(2002) , 10.1038/NRG906
J C Davis, S Manzi, C Yarboro, J Rairie, I Mcinnes, D Averthelyi, D Sinicropi, V G Hale, J Balow, H Austin, D T Boumpas, J H Klippel, Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus. ,vol. 8, pp. 68- 76 ,(1999) , 10.1191/096120399678847380
Joshua A. Beckman, Mark A. Creager, Peter Libby, Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management JAMA. ,vol. 287, pp. 2570- 2581 ,(2002) , 10.1001/JAMA.287.19.2570
Trish M Perl, The threat of vancomycin resistance. The American Journal of Medicine. ,vol. 106, pp. 26- 37 ,(1999) , 10.1016/S0002-9343(98)00354-4
Michael B Clearfield, Statins: balancing benefits, efficacy and safety. Expert Opinion on Pharmacotherapy. ,vol. 3, pp. 469- 477 ,(2002) , 10.1517/14656566.3.5.469
Dawn E. DeWitt, Irl B. Hirsch, Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus JAMA. ,vol. 289, pp. 2254- 2264 ,(2003) , 10.1001/JAMA.289.17.2254